Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-203 in Bullous Pemphigoid
NCT03286582Phase 2Terminated
- Sponsor
- TWi Biotechnology, Inc.
- Start
- Sep 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AC-203 in Bullous Pemphigoid (BP), sponsored by TWi Biotechnology, Inc.. Started Sep 2017; status: terminated.
02
Drugs
AC-203
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on NCT03286582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03286582.